We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Thermo Fisher Scientific Acquires MTI-GlobalStem
News

Thermo Fisher Scientific Acquires MTI-GlobalStem

Thermo Fisher Scientific Acquires MTI-GlobalStem
News

Thermo Fisher Scientific Acquires MTI-GlobalStem

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Thermo Fisher Scientific Acquires MTI-GlobalStem"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Thermo Fisher Scientific announced it has signed a purchase agreement to acquire MTI-GlobalStem, a privately-held company that develops and commercializes leading-edge technology and reagents for cell transfection, neurobiology and stem cell research applications. 

Completion of the transaction follows the receipt of all required regulatory approvals. Per the agreement, no further details of the transaction are being provided. Based in Gaithersburg, Md., MTI-GlobalStem will be folded into Thermo Fisher’s life sciences solutions segment.

“The addition of MTI-GlobalStem’s technology further strengthens Thermo Fisher’s leadership in biosciences and provides scientists around the world with access to a wider array of advanced research products designed to help accelerate discovery using cell models,” said Amy Butler, vice president and general manager of Cell Biology for Thermo Fisher Scientific. “Their technology and expertise, combined with Thermo Fisher’s global commercial reach, is a strategic fit that enables us to better serve our transfection and stem cell research customers.”

Source:

Story from Thermo Fisher Scientific. Please note: The content above may have been edited to ensure it is in keeping with Technology Networks’ style and length guidelines.

Advertisement